Crescent Biopharma (CBIO) EPS (Basic) (2013 - 2026)
Crescent Biopharma (CBIO) reported EPS (Basic) of -$0.84 for Q1 2026, down 2011.11% year-over-year from $0.04 in Q1 2025, and up 74.26% on a QoQ basis from -$3.28 in Q4 2025.
Crescent Biopharma (CBIO) has 14 years of EPS (Basic) data on file, last reported at -$0.84 in Q1 2026.
- Quarterly EPS (Basic) fell 2011.11% year-over-year to -$0.84 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$7.46 (down 1522.73% YoY) and the FY2025 annual result came in at -$5.59, down 846.84% from the prior year.
- EPS (Basic) improved to -$0.84 in Q1 2026 per CBIO's latest filing, from -$3.28 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.04 in Q1 2025 and bottomed at -$3.28 in Q4 2025.
- The 5-year median for EPS (Basic) is -$0.17 (2023), against an average of -$0.56.
- Peak annual rise in EPS (Basic) reached 76.47% in 2025, while the deepest fall reached 2882.17% in 2025.
- Tracing CBIO's EPS (Basic) over 5 years: stood at -$0.19 in 2022, then gained by 26.32% to -$0.14 in 2023, then increased by 21.43% to -$0.11 in 2024, then plunged by 2882.17% to -$3.28 in 2025, then soared by 74.26% to -$0.84 in 2026.
- Per Business Quant, the three latest CBIO EPS (Basic) figures stand at -$0.84 (Q1 2026), -$3.28 (Q4 2025), and -$1.77 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 3.06 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 0.00 |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 0.00 |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 4.06 |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 0.00 |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 6.99 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 1.55 |
| 10 | Crescent Biopharma | 569.36 Mn | 380.20 Mn | - | -0.84 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.84 |
| Dec 31, 2025 | -3.28 |
| Sep 30, 2025 | -1.77 |
| Jun 30, 2025 | -1.57 |
| Mar 31, 2025 | -0.04 |
| Dec 31, 2024 | -0.11 |
| Sep 30, 2024 | -0.15 |
| Jun 30, 2024 | -0.16 |
| Mar 31, 2024 | -0.17 |
| Dec 31, 2023 | -0.14 |
| Sep 30, 2023 | -0.14 |
| Jun 30, 2023 | -0.13 |
| Mar 31, 2023 | -0.17 |
| Dec 31, 2022 | -0.19 |
| Sep 30, 2022 | -0.16 |
| Jun 30, 2022 | -0.25 |
| Mar 31, 2022 | -0.28 |
| Dec 31, 2021 | -0.33 |
| Sep 30, 2021 | -0.34 |
| Jun 30, 2021 | -0.28 |
| Mar 31, 2021 | -0.28 |
| Dec 31, 2020 | -0.33 |
| Sep 30, 2020 | -0.29 |
| Jun 30, 2020 | -0.32 |
| Mar 31, 2020 | -0.18 |
| Dec 31, 2019 | -0.34 |
| Sep 30, 2019 | -0.31 |
| Jun 30, 2019 | -0.37 |
| Mar 31, 2019 | -0.33 |
| Dec 31, 2018 | -0.32 |
| Sep 30, 2018 | -0.27 |
| Jun 30, 2018 | -0.26 |
| Mar 31, 2018 | -0.33 |
| Dec 31, 2017 | -0.27 |
| Sep 30, 2017 | -0.24 |
| Jun 30, 2017 | -0.30 |
| Mar 31, 2017 | -0.34 |
| Dec 31, 2016 | -0.36 |
| Sep 30, 2016 | -0.34 |
| Jun 30, 2016 | -0.41 |
| Mar 31, 2016 | -0.40 |
| Dec 31, 2015 | -0.47 |
| Sep 30, 2015 | -0.38 |
| Jun 30, 2015 | 0.55 |
| Mar 31, 2015 | -0.37 |
| Dec 31, 2014 | -0.39 |
| Sep 30, 2014 | -0.35 |
| Jun 30, 2014 | 0.42 |
| Mar 31, 2014 | -0.30 |
| Dec 31, 2013 | -2.80 |
| Sep 30, 2013 | -3.00 |
| Jun 30, 2013 | -3.70 |
| Mar 31, 2013 | 0.49 |